Previous 10 | Next 10 |
Endo Comments on Tennessee Appeals Court Orders Canada NewsWire DUBLIN , July 15, 2021 /CNW/ -- Endo International plc (NASDAQ: ENDP) today announced the issuance of several orders by the Tennessee Supreme Court and the Tennessee Court of Appeals regardi...
The denied request is likely the last chance to stop the Tennessee damages trial set to begin on July 26. The company already has a default judgment against it. The company could face a $2.4 billion judgment leveled against it. Appeal denial is one more piece pointing to likel...
Mario Tama/Getty Images News Despite headwinds facing Endo International ([[ENDP]] -1.5%), such as settlements and litigation relating to the prescription opioid crisis, Citi is reiterating its buy rating on shares. The bank is also maintaining its $11 price target (190% upside). Analyst Nava...
The market is off to a great start this year. A look below the surface reveals plenty of great stocks at reasonable prices. S&P 500 is up 14.4% YTD - a very respectable start for any year, and especially one that is digging its way out of a large economic hole. Buying high qua...
A Tennessee state court issued a "default judgement" in April against the company in the lawsuit by county prosecutors over the company's generic for oxycontin, Opana. Earlier this month, a Tennessee appellate court declined to review that default judgement. The damages trial...
Comstock/Stockbyte via Getty Images A lawsuit that accuses several major drugmakers and three national drug distributors of helping to fuel the nation's prescription opioid epidemic goes to a jury trial today in Central Islip, N.Y. Defendants in the case include drugmakers Abbvie ([[ABBV]] -1...
Endo to Announce Second Quarter 2021 Financial Results Canada NewsWire DUBLIN , June 24, 2021 /CNW/ -- Endo International plc (NASDAQ: ENDP) will announce its second–quarter 2021 financial results on August 5, 2021 after the U.S. financial markets...
Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data to Be Presented at Cosmetic Bootcamp 2021 Canada NewsWire DUBLIN , June 24, 2021 /CNW/ -- Endo International plc (NASDAQ:ENDP) announced today that data from studies of Endo Aesthetics' Qwo...
Gainers: Idera Pharmaceuticals (IDRA) +22%, Beyond Air (XAIR) +14%, Clover Health Investments (CLOV) +14%, Adial Pharmaceuticals (ADIL) +13%, CollPlant Biotechnologies (CLGN) +10%.Losers: Mereo BioPharma (MREO) -9%, Portage Biotech (PRTG) -9%, ...
selvanegra/iStock via Getty Images The FDA has approved Micafungin injection for several infections after a new drug application ((NDA)) submitted in 2019 by Par Sterile Products, a subsidiary of Endo International ([[ENDP]] +0.3%). Per the letter issued by the regulator f...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...